Jane Street
JBIO

Jane Street’s Jade Biosciences JBIO Stock Holding History

Jane Street’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-315
Closed -$27.6K – 9591
2025
Q1 		$27.6K Buy
+315
New +$27.7K ﹤0.01% 9103
2024
Q4 		– Sell
-509
Closed -$37.2K – 9364
2024
Q3 		$37.2K Sell
509
-2,641
-84% -$170K ﹤0.01% 9213
2024
Q2 		$183K Buy
3,150
+2,828
+878% +$1.88M ﹤0.01% 8457
2024
Q1 		$333K Sell
322
-52
-14% -$39.7K ﹤0.01% 7392
2023
Q4 		$297K Buy
+374
New +$191K ﹤0.01% 7613
2022
Q3 		– Sell
-335
Closed -$183K – 9673
2022
Q2 		$183K Buy
+335
New +$160K ﹤0.01% 8256
2022
Q1 		– Sell
-355
Closed -$146K – 10258
2021
Q4 		$146K Buy
+355
New +$180K ﹤0.01% 9018

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jane Street's JBIO Position: Q2 2025 in Review

Jane Street sold out of Jade Biosciences (JBIO) in Q2 2025, closing a stake of 315 shares — an estimated $27.6K sold.

Jane Street first reported a position in JBIO in Q4 2021 and held it in 7 quarters. The position peaked at $333K in Q1 2024. 75 funds tracked by Wall St. Rank hold JBIO as of Q2 2025.

  • Jane Street reported no remaining Jade Biosciences position as of Q2 2025 after selling out during the quarter.
  • Jane Street sold 315 Jade Biosciences shares in Q2 2025, an estimated $27.6K.
  • Jane Street first reported a position in Jade Biosciences in Q4 2021 and held it in 7 quarters.
  • Jane Street's Jade Biosciences position peaked at $333K in Q1 2024.
  • 75 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.